Johnson & Johnson (JNJ) Net Cash Flow (2009 - 2026)
Johnson & Johnson recorded quarterly Net Cash Flow of $2.0 billion in Q1 2026, up 37.73% quarter-over-quarter from $1.5 billion in Q4 2025, and down 85.99% year-over-year from $14.3 billion in Q1 2025.
Johnson & Johnson's Net Cash Flow history runs 18 years deep, the most recent figure standing at $2.0 billion for Q1 2026.
- In Q1 2026, Net Cash Flow fell 85.99% year-over-year to $2.0 billion; the TTM figure through Mar 2026 stood at -$16.9 billion (down 229.0% YoY), while the FY2025 annual figure was -$4.6 billion, down 281.34% from the prior year.
- Net Cash Flow came in at $2.0 billion for Q1 2026 at Johnson & Johnson, up from $1.5 billion in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $14.3 billion in Q1 2025 to a low of -$20.1 billion in Q2 2025.
- A 5-year average of -$3.1 million and a median of -$300.0 million in 2025 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow jumped 414.6% in 2023 and plunged 3831.57% in 2025, its largest moves.
- Johnson & Johnson's Net Cash Flow stood at -$4.0 billion in 2022, then jumped by 149.65% to $2.0 billion in 2023, then surged by 115.5% to $4.3 billion in 2024, then sank by 66.34% to $1.5 billion in 2025, then jumped by 37.73% to $2.0 billion in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $2.0 billion, $1.5 billion, and -$300.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -2.05 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 2.00 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 4.17 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -9.27 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 2.91 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 75.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 544.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -587.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 2.00 Bn |
| Mar 29, 2026 | 2.00 Bn |
| Dec 28, 2025 | 1.46 Bn |
| Dec 28, 2025 | 1.46 Bn |
| Sep 28, 2025 | -300.00 Mn |
| Sep 28, 2025 | -300.00 Mn |
| Jun 29, 2025 | -20.05 Bn |
| Jun 29, 2025 | -20.05 Bn |
| Mar 30, 2025 | 14.30 Bn |
| Mar 30, 2025 | 14.30 Bn |
| Dec 29, 2024 | 4.32 Bn |
| Dec 29, 2024 | 4.32 Bn |
| Sep 29, 2024 | -5.02 Bn |
| Sep 29, 2024 | -5.02 Bn |
| Jun 30, 2024 | -510.00 Mn |
| Jun 30, 2024 | -510.00 Mn |
| Mar 31, 2024 | 3.74 Bn |
| Mar 31, 2024 | 3.74 Bn |
| Dec 31, 2023 | 2.01 Bn |
| Dec 31, 2023 | 2.01 Bn |
| Oct 1, 2023 | -1.29 Bn |
| Oct 1, 2023 | -1.29 Bn |
| Jul 2, 2023 | -5.59 Bn |
| Jul 2, 2023 | -5.59 Bn |
| Apr 2, 2023 | 12.71 Bn |
| Apr 2, 2023 | 12.71 Bn |
| Jan 1, 2023 | -3.79 Bn |
| Jan 1, 2023 | -3.79 Bn |
| Apr 3, 2022 | -4.04 Bn |
| Apr 3, 2022 | -4.04 Bn |
| Oct 3, 2021 | 3.36 Bn |
| Oct 3, 2021 | 3.36 Bn |
| Jul 4, 2021 | 1.62 Bn |
| Jul 4, 2021 | 1.62 Bn |
| Apr 4, 2021 | -1.24 Bn |
| Apr 4, 2021 | -1.24 Bn |
| Jan 3, 2021 | -5.20 Bn |
| Jan 3, 2021 | -5.20 Bn |
| Sep 27, 2020 | 7.76 Bn |
| Sep 27, 2020 | 7.76 Bn |
| Jun 28, 2020 | -4.43 Bn |
| Jun 28, 2020 | -4.43 Bn |
| Mar 29, 2020 | -1.54 Bn |
| Mar 29, 2020 | -1.54 Bn |
| Dec 29, 2019 | 982.00 Mn |
| Dec 29, 2019 | 982.00 Mn |
| Sep 29, 2019 | 1.99 Bn |
| Sep 29, 2019 | 1.99 Bn |
| Jun 30, 2019 | -374.00 Mn |
| Jun 30, 2019 | -374.00 Mn |
| Mar 31, 2019 | -3.39 Bn |
| Mar 31, 2019 | -3.39 Bn |
| Dec 30, 2018 | 2.08 Bn |
| Dec 30, 2018 | 2.08 Bn |
| Sep 30, 2018 | -1.47 Bn |
| Sep 30, 2018 | -1.47 Bn |
| Jul 1, 2018 | 3.20 Bn |
| Jul 1, 2018 | 3.20 Bn |
| Apr 1, 2018 | -3.29 Bn |
| Apr 1, 2018 | -3.29 Bn |
| Dec 31, 2017 | 2.06 Bn |
| Dec 31, 2017 | 2.06 Bn |
| Oct 1, 2017 | 3.02 Bn |
| Oct 1, 2017 | 3.02 Bn |
| Jul 2, 2017 | -8.39 Bn |
| Jul 2, 2017 | -8.39 Bn |
| Apr 2, 2017 | 1.83 Bn |
| Apr 2, 2017 | 1.83 Bn |
| Jan 1, 2017 | 5.16 Bn |
| Jan 1, 2017 | 5.16 Bn |
| Apr 3, 2016 | 48.00 Mn |
| Apr 3, 2016 | 48.00 Mn |
| Sep 27, 2015 | 3.30 Bn |
| Sep 27, 2015 | 3.30 Bn |
| Jun 28, 2015 | -857.00 Mn |
| Jun 28, 2015 | -857.00 Mn |
| Mar 29, 2015 | -2.14 Bn |
| Mar 29, 2015 | -2.14 Bn |
| Dec 28, 2014 | 824.00 Mn |
| Dec 28, 2014 | 824.00 Mn |
| Sep 28, 2014 | -327.00 Mn |
| Sep 28, 2014 | -327.00 Mn |
| Jun 29, 2014 | -5.43 Bn |
| Jun 29, 2014 | -5.43 Bn |
| Mar 30, 2014 | -1.16 Bn |
| Mar 30, 2014 | -1.16 Bn |
| Dec 29, 2013 | 3.74 Bn |
| Dec 29, 2013 | 3.74 Bn |
| Sep 29, 2013 | -125.00 Mn |
| Sep 29, 2013 | -125.00 Mn |
| Jun 30, 2013 | 2.51 Bn |
| Jun 30, 2013 | 2.51 Bn |
| Mar 31, 2013 | 97.00 Mn |
| Mar 31, 2013 | 97.00 Mn |
| Dec 30, 2012 | -598.00 Mn |
| Dec 30, 2012 | -598.00 Mn |
| Sep 30, 2012 | 1.39 Bn |
| Sep 30, 2012 | 1.39 Bn |
| Jul 1, 2012 | -16.14 Bn |
| Jul 1, 2012 | -16.14 Bn |
| Apr 1, 2012 | 5.67 Bn |
| Apr 1, 2012 | 5.67 Bn |
| Jan 1, 2012 | 6.71 Bn |
| Jan 1, 2012 | 6.71 Bn |
| Apr 3, 2011 | 2.93 Bn |
| Apr 3, 2011 | 2.93 Bn |
| Oct 3, 2010 | 1.46 Bn |
| Oct 3, 2010 | 1.46 Bn |
| Jul 4, 2010 | -921.00 Mn |
| Jul 4, 2010 | -921.00 Mn |
| Apr 4, 2010 | -2.01 Bn |
| Apr 4, 2010 | -2.01 Bn |
| Jan 3, 2010 | 4.00 Bn |
| Jan 3, 2010 | 4.00 Bn |
| Sep 27, 2009 | -3.00 Mn |
| Sep 27, 2009 | -3.00 Mn |
| Jun 28, 2009 | -1.00 Bn |
| Jun 28, 2009 | -1.00 Bn |
| Mar 29, 2009 | 1.88 Bn |
| Mar 29, 2009 | 1.88 Bn |